Stock NKTR NEKTAR THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Nektar Therapeutics

Equities

NKTR

US6402681083

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
1.46 USD +10.61% Intraday chart for Nektar Therapeutics +7.35% +158.41%
Apr. 24 Biolojic Design Announces Nektar Therapeutics Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases CI
Mar. 19 Nektar Therapeutics announced that it has received $30 million in funding from TCG Crossover Management, LLC CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. NKTR Stock
  4. News Nektar Therapeutics
  5. Official Publications